Search
Search Results
##search.searchResults.foundPlural##
-
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3096PDF: 1084HTML: 7536 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
328PDF: 822HTML: 83 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3682PDF: 1508HTML: 2758 -
-
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
957PDF: 542HTML: 1334 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4295PDF: 1375HTML: 2138Table 1: 265 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4782Suppl. Files: 1305PDF: 1202Html: 357 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
2156PDF: 1228HTML: 1953Lung computed tomography CT scan image: 261 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1562PDF: 896HTML: 1047 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1140PDF: 590HTML: 762 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8682PDF: 4674HTML: 7638 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3649PDF: 1381HTML: 8445 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3783PDF: 1673HTML: 4588CoverLetter: 319Figure1: 330 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
8035PDF: 2553HTML: 2185Table 1.: 300Table 2.: 326Table 3.: 280Table 4.: 288 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3905PDF: 2695HTML: 1733 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3951PDF: 1402HTML: 3985Untitled: 316Untitled: 335 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2906PDF: 1040HTML: 625 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4282PDF: 1267HTML: 2140Fig.1: 262Fig. 2: 152Table 1: 269Table2: 297Table 3: 288 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4536PDF: 1495HTML: 2221 -
MAGNUSIOMYCES CAPITATUS BREAKTHROUGH INFECTION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RECEIVING ECHINOCANDIN PROPHYLAXIS: CLINICAL FEATURES, MANAGEMENT, AND REVIEW OF THE LITERATURE
230PDF: 266Suppl. Files: 57Html: 126Html Suppl. Files: 111 -
-
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2792PDF: 1779HTML: 2478Table1: 322 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1376PDF: 603HTML: 23270 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
4387PDF: 2128HTML: 295







